NEURii: developing digital solutions for dementia
Eisai, Gates Ventures, Health Data Research UK (HDR UK), LifeArc and The University of Edinburgh have announced a new two-year collaborative research agreement.
Source: outsourcing-pharma.com
Teiji Kimura News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Teiji Kimura. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Teiji Kimura Today - Breaking & Trending Today
EISAI AND WASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUIS ENTER INTO COMPREHENSIVE RESEARCH COLLABORATION AGREEMENT AIMING TO CREATE NEW THERAPIES FOR NEURODEGENERATIVE DISEASES
/PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that Eisai and Washington University School of Medicine in St....
Source: prnewswire.com
Eisai and Washington University partner for new therapies
Eisai has entered an agreement with Washington University School of Medicine to develop new therapies for neurodegenerative ailments.
Source: pharmaceutical-technology.com
WashU, Eisai form drug discovery collaboration - The Source - Washington University in St. Louis
Washington University School of Medicine in St. Louis and pharmaceutical company Eisai Co. Ltd. have formed a research collaboration aimed at developing new treatments for Alzheimer’s disease and other neurodegenerative conditions.
Source: wustl.edu